NovaBay Pharmaceuticals Inc (NBY)
0.0892
+0.01
(+10.40%)
USD |
NYAM |
May 01, 16:00
0.0892
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Accounts Receivable (Quarterly): 0.759M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.759M |
September 30, 2023 | 0.916M |
June 30, 2023 | 2.623M |
March 31, 2023 | 1.835M |
December 31, 2022 | 1.973M |
September 30, 2022 | 2.133M |
June 30, 2022 | 1.098M |
March 31, 2022 | 2.30M |
December 31, 2021 | 1.668M |
September 30, 2021 | 0.843M |
June 30, 2021 | 1.232M |
March 31, 2021 | 1.038M |
December 31, 2020 | 1.106M |
September 30, 2020 | 1.119M |
June 30, 2020 | 1.391M |
March 31, 2020 | 0.952M |
December 31, 2019 | 1.066M |
September 30, 2019 | 1.505M |
June 30, 2019 | 1.536M |
March 31, 2019 | 2.43M |
December 31, 2018 | 3.385M |
September 30, 2018 | 2.612M |
June 30, 2018 | 2.024M |
March 31, 2018 | 2.225M |
December 31, 2017 | 3.629M |
Date | Value |
---|---|
September 30, 2017 | 2.23M |
June 30, 2017 | 3.601M |
March 31, 2017 | 2.331M |
December 31, 2016 | 2.12M |
September 30, 2016 | 2.079M |
June 30, 2016 | 1.49M |
March 31, 2016 | 1.497M |
December 31, 2015 | 0.536M |
September 30, 2015 | 0.543M |
June 30, 2015 | 0.389M |
March 31, 2015 | 0.283M |
December 31, 2014 | 0.273M |
September 30, 2014 | 0.364M |
June 30, 2014 | 0.44M |
March 31, 2014 | 0.26M |
December 31, 2013 | 0.784M |
September 30, 2013 | 0.272M |
June 30, 2013 | 0.112M |
March 31, 2013 | 0.916M |
December 31, 2012 | 0.943M |
September 30, 2012 | 0.126M |
June 30, 2012 | 0.009M |
March 31, 2012 | 1.009M |
December 31, 2011 | 0.003M |
September 30, 2011 | 1.825M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.759M
Minimum
Dec 2023
2.623M
Maximum
Jun 2023
1.426M
Average
1.232M
Median
Jun 2021
Accounts Receivable (Quarterly) Benchmarks
Eyenovia Inc | -- |
Palatin Technologies Inc | 2.346M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |